Drug,Drug Mechanism,Target Gene(s),Drug Constrained Regulon Activity,Drug Constrained Program Activity,All Regulon(s),Overactive Regulon(s),Underactive Regulon(s),All Program(s),Overactive Program(s),Underactive Program(s),Regulon Activity Summary,Program Activity Summary,Mutations,Regulators,MINER Target Type,max_glioblastoma.multiforme_phase,Other FDA Appr.,TargetMutatedInPatient,MutatedInPatient,TargetType,MutatedDetail,Drug Action,Molecule Type,Target Class,Toxicity Class,MEDDRA Code,CHEMBL_ID,Reactome,GO,Hallmarks
CARMUSTINE,RNA inhibitor:DNA inhibitor:Glutathione reductase inhibitor,GSR,1,1,"1663,2320,2679,41,644,681,707","1663,2320,2679,41,644,681,707",NA,101,101,NA,O: 7 U: 0 A: 7,O: 1 U: 0 A: 1,,,Regulon_Gene,4,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR:INHIBITOR:INHIBITOR,Small molecule,Enzyme,,,CHEMBL513,NA:NA:NA:NA:NA,GO_STRESS_GRANULE_ASSEMBLY:GO_REGULATION_OF_CIRCADIAN_RHYTHM:NA:NA:NA,
VALPROIC ACID,Succinate semialdehyde dehydrogenase inhibitor,ALDH5A1,1,0,1021,1021,NA,132,NA,NA,O: 1 U: 0 A: 1,O: 0 U: 0 A: 1,,,Regulon_Gene,1,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,Hepatotoxicity:Teratogenicity:Gastrotoxicity:Hepatotoxicity:Hepatotoxicity:Teratogenicity:Teratogenicity:Gastrotoxicity:Gastrotoxicity,10019805.0:10010331.0:10017947.0:10019805.0:10019805.0:10010331.0:10010331.0:10017947.0:10017947.0,CHEMBL109,PI3K events in ERBB4 signaling:PI3K events in ERBB2 signaling:Signaling by ERBB2 KD Mutants:Signaling by ERBB2 in Cancer:ESR-mediated signaling,GO_POSITIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY:GO_MATING_BEHAVIOR:GO_REPRODUCTIVE_BEHAVIOR:GO_POSITIVE_REGULATION_OF_MONOOXYGENASE_ACTIVITY:GO_ERBB2_SIGNALING_PATHWAY,HALLMARK_ESTROGEN_RESPONSE_EARLY:HALLMARK_MYOGENESIS
VALPROATE SODIUM,Succinate semialdehyde dehydrogenase inhibitor,ALDH5A1,1,0,1021,1021,NA,132,NA,NA,O: 1 U: 0 A: 1,O: 0 U: 0 A: 1,,,Regulon_Gene,1,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,Hepatotoxicity:Teratogenicity:Gastrotoxicity,10019805.0:10010331.0:10017947.0,CHEMBL433,PI3K events in ERBB4 signaling:PI3K events in ERBB2 signaling:Signaling by ERBB2 KD Mutants:Signaling by ERBB2 in Cancer:ESR-mediated signaling,GO_POSITIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY:GO_MATING_BEHAVIOR:GO_REPRODUCTIVE_BEHAVIOR:GO_POSITIVE_REGULATION_OF_MONOOXYGENASE_ACTIVITY:GO_ERBB2_SIGNALING_PATHWAY,HALLMARK_ESTROGEN_RESPONSE_EARLY:HALLMARK_MYOGENESIS
KB-004,Ephrin type-A receptor 3 inhibitor,EPHA3,1,1,"1147,1249,1718,2062,2934,722","1147,1249,1718,2062,2934,722",NA,63,63,NA,O: 6 U: 0 A: 6,O: 1 U: 0 A: 1,,,Regulon_Gene,1,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Antibody,Enzyme,,,CHEMBL2109398,"Extra-nuclear estrogen signaling:FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes:ESR-mediated signaling:Signaling by Nuclear Receptors:FOXO-mediated transcription",GO_INSULIN_RECEPTOR_SIGNALING_PATHWAY:NA:NA:NA:NA,
DIVALPROEX SODIUM,Succinate semialdehyde dehydrogenase inhibitor,ALDH5A1,1,0,1021,1021,NA,132,NA,NA,O: 1 U: 0 A: 1,O: 0 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,Hepatotoxicity:Teratogenicity:Gastrotoxicity,10019805.0:10010331.0:10017947.0,CHEMBL2105613,PI3K events in ERBB4 signaling:PI3K events in ERBB2 signaling:Signaling by ERBB2 KD Mutants:Signaling by ERBB2 in Cancer:ESR-mediated signaling,GO_POSITIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY:GO_MATING_BEHAVIOR:GO_REPRODUCTIVE_BEHAVIOR:GO_POSITIVE_REGULATION_OF_MONOOXYGENASE_ACTIVITY:GO_ERBB2_SIGNALING_PATHWAY,HALLMARK_ESTROGEN_RESPONSE_EARLY:HALLMARK_MYOGENESIS
OXIGLUTATIONE,Glutathione reductase,GSR,1,1,"1663,2320,2679,41,644,681,707","1663,2320,2679,41,644,681,707",NA,101,101,NA,O: 7 U: 0 A: 7,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,OTHER,Small molecule,Enzyme,,,CHEMBL1372,NA:NA:NA:NA:NA,GO_STRESS_GRANULE_ASSEMBLY:GO_REGULATION_OF_CIRCADIAN_RHYTHM:NA:NA:NA,
SIMPINICLINE,Neuronal acetylcholine receptor; alpha4/beta2 agonist:Neuronal acetylcholine receptor; alpha3/beta4 agonist,CHRNB4,1,0,1269,1269,NA,150,NA,NA,O: 1 U: 0 A: 1,O: 0 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,AGONIST:AGONIST,Small molecule,Ion channel,,,CHEMBL4594254,GP1b-IX-V activation signalling:Presynaptic nicotinic acetylcholine receptors:Highly calcium permeable postsynaptic nicotinic acetylcholine receptors:Neurotransmitter receptors and postsynaptic signal transmission:Creation of C4 and C2 activators,NA:NA:NA:NA:NA,HALLMARK_COAGULATION
LARAZOTIDE,Neuronal acetylcholine receptor; alpha3/beta4 partial agonist,CHRNB4,1,0,1269,1269,NA,150,NA,NA,O: 1 U: 0 A: 1,O: 0 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,PARTIAL AGONIST,Protein,Ion channel,,,CHEMBL2105646,GP1b-IX-V activation signalling:Presynaptic nicotinic acetylcholine receptors:Highly calcium permeable postsynaptic nicotinic acetylcholine receptors:Neurotransmitter receptors and postsynaptic signal transmission:Creation of C4 and C2 activators,NA:NA:NA:NA:NA,HALLMARK_COAGULATION
TRIMETHAPHAN,Neuronal acetylcholine receptor; alpha3/beta4 antagonist,CHRNB4,1,0,1269,1269,NA,150,NA,NA,O: 1 U: 0 A: 1,O: 0 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,ANTAGONIST,Small molecule,Ion channel,,,CHEMBL1201329,GP1b-IX-V activation signalling:Presynaptic nicotinic acetylcholine receptors:Highly calcium permeable postsynaptic nicotinic acetylcholine receptors:Neurotransmitter receptors and postsynaptic signal transmission:Creation of C4 and C2 activators,NA:NA:NA:NA:NA,HALLMARK_COAGULATION
LARAZOTIDE ACETATE,Neuronal acetylcholine receptor; alpha3/beta4 partial agonist,CHRNB4,1,0,1269,1269,NA,150,NA,NA,O: 1 U: 0 A: 1,O: 0 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,PARTIAL AGONIST,Protein,Ion channel,,,CHEMBL2103815,GP1b-IX-V activation signalling:Presynaptic nicotinic acetylcholine receptors:Highly calcium permeable postsynaptic nicotinic acetylcholine receptors:Neurotransmitter receptors and postsynaptic signal transmission:Creation of C4 and C2 activators,NA:NA:NA:NA:NA,HALLMARK_COAGULATION
MECAMYLAMINE HYDROCHLORIDE,Neuronal acetylcholine receptor; alpha3/beta4 negative allosteric modulator,CHRNB4,1,0,1269,1269,NA,150,NA,NA,O: 1 U: 0 A: 1,O: 0 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,NEGATIVE ALLOSTERIC MODULATOR,Small molecule,Ion channel,,,CHEMBL1237082,GP1b-IX-V activation signalling:Presynaptic nicotinic acetylcholine receptors:Highly calcium permeable postsynaptic nicotinic acetylcholine receptors:Neurotransmitter receptors and postsynaptic signal transmission:Creation of C4 and C2 activators,NA:NA:NA:NA:NA,HALLMARK_COAGULATION
MECAMYLAMINE,Neuronal acetylcholine receptor; alpha3/beta4 negative allosteric modulator,CHRNB4,1,0,1269,1269,NA,150,NA,NA,O: 1 U: 0 A: 1,O: 0 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,NEGATIVE ALLOSTERIC MODULATOR,Small molecule,Ion channel,,,CHEMBL267936,GP1b-IX-V activation signalling:Presynaptic nicotinic acetylcholine receptors:Highly calcium permeable postsynaptic nicotinic acetylcholine receptors:Neurotransmitter receptors and postsynaptic signal transmission:Creation of C4 and C2 activators,NA:NA:NA:NA:NA,HALLMARK_COAGULATION
FLUMATINIB,Tyrosine-protein kinase ABL inhibitor,ABL1,1,1,"1011,1034,1092,1152,1180","1011,1034,1092,1152,1180",NA,65,65,NA,O: 5 U: 0 A: 5,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL3545413,Chromatin modifying enzymes:Chromatin organization:RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known:Transcriptional regulation by RUNX1:Transcriptional Regulation by TP53,GO_CHROMATIN_DISASSEMBLY:GO_PROTEIN_DNA_COMPLEX_DISASSEMBLY:GO_COVALENT_CHROMATIN_MODIFICATION:GO_CHROMATIN_REMODELING:GO_PEPTIDYL_LYSINE_MODIFICATION,HALLMARK_MITOTIC_SPINDLE:HALLMARK_G2M_CHECKPOINT
NILOTINIB HYDROCHLORIDE MONOHYDRATE,Tyrosine-protein kinase ABL inhibitor,ABL1,1,1,"1011,1034,1092,1152,1180","1011,1034,1092,1152,1180",NA,65,65,NA,O: 5 U: 0 A: 5,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL1201740,Chromatin modifying enzymes:Chromatin organization:RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known:Transcriptional regulation by RUNX1:Transcriptional Regulation by TP53,GO_CHROMATIN_DISASSEMBLY:GO_PROTEIN_DNA_COMPLEX_DISASSEMBLY:GO_COVALENT_CHROMATIN_MODIFICATION:GO_CHROMATIN_REMODELING:GO_PEPTIDYL_LYSINE_MODIFICATION,HALLMARK_MITOTIC_SPINDLE:HALLMARK_G2M_CHECKPOINT
REBASTINIB,Tyrosine-protein kinase ABL inhibitor,ABL1,1,1,"1011,1034,1092,1152,1180","1011,1034,1092,1152,1180",NA,65,65,NA,O: 5 U: 0 A: 5,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL1738757,Chromatin modifying enzymes:Chromatin organization:RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known:Transcriptional regulation by RUNX1:Transcriptional Regulation by TP53,GO_CHROMATIN_DISASSEMBLY:GO_PROTEIN_DNA_COMPLEX_DISASSEMBLY:GO_COVALENT_CHROMATIN_MODIFICATION:GO_CHROMATIN_REMODELING:GO_PEPTIDYL_LYSINE_MODIFICATION,HALLMARK_MITOTIC_SPINDLE:HALLMARK_G2M_CHECKPOINT
NILOTINIB,Tyrosine-protein kinase ABL inhibitor,ABL1,1,1,"1011,1034,1092,1152,1180","1011,1034,1092,1152,1180",NA,65,65,NA,O: 5 U: 0 A: 5,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,Cardiotoxicity,10007541,CHEMBL255863,Chromatin modifying enzymes:Chromatin organization:RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known:Transcriptional regulation by RUNX1:Transcriptional Regulation by TP53,GO_CHROMATIN_DISASSEMBLY:GO_PROTEIN_DNA_COMPLEX_DISASSEMBLY:GO_COVALENT_CHROMATIN_MODIFICATION:GO_CHROMATIN_REMODELING:GO_PEPTIDYL_LYSINE_MODIFICATION,HALLMARK_MITOTIC_SPINDLE:HALLMARK_G2M_CHECKPOINT
ASCIMINIB,Tyrosine-protein kinase ABL inhibitor,ABL1,1,1,"1011,1034,1092,1152,1180","1011,1034,1092,1152,1180",NA,65,65,NA,O: 5 U: 0 A: 5,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL4208229,Chromatin modifying enzymes:Chromatin organization:RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known:Transcriptional regulation by RUNX1:Transcriptional Regulation by TP53,GO_CHROMATIN_DISASSEMBLY:GO_PROTEIN_DNA_COMPLEX_DISASSEMBLY:GO_COVALENT_CHROMATIN_MODIFICATION:GO_CHROMATIN_REMODELING:GO_PEPTIDYL_LYSINE_MODIFICATION,HALLMARK_MITOTIC_SPINDLE:HALLMARK_G2M_CHECKPOINT
OMECAMTIV MECARBIL,Cardiac myosin activator,MYH7,1,1,373,373,NA,66,66,NA,O: 1 U: 0 A: 1,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,ACTIVATOR,Small molecule,Unclassified protein,,,CHEMBL1800955,NA:NA:NA:NA:NA,GO_PROTEIN_DESTABILIZATION:NA:NA:NA:NA,
LY-2584702,Ribosomal protein S6 kinase 1 inhibitor,RPS6KB1,1,1,2977,2977,NA,70,70,NA,O: 1 U: 0 A: 1,O: 1 U: 0 A: 1,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL3545076,NA:NA:NA:NA:NA,NA:NA:NA:NA:NA,
TCD-717,Choline kinase alpha inhibitor,CHKA,1,1,"1527,1664,1737","1527,1664,1737",NA,"52,73","52,73",NA,O: 3 U: 0 A: 3,O: 2 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,INHIBITOR,Small molecule,Enzyme,,,CHEMBL3545084,NA:NA:NA:NA:NA,NA:NA:NA:NA:NA,
BIMAGRUMAB,Activin receptor type-2B antagonist,ACVR2B,1,1,"1011,1092,1112,1152,1568,987","1011,1092,1112,1152,1568,987",NA,"65,66","65,66",NA,O: 6 U: 0 A: 6,O: 2 U: 0 A: 2,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,ANTAGONIST,Antibody,Enzyme,,,CHEMBL3137353,Chromatin modifying enzymes:Chromatin organization:RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known:Transcriptional regulation by RUNX1:Transcriptional Regulation by TP53,GO_PEPTIDYL_LYSINE_MODIFICATION:GO_COVALENT_CHROMATIN_MODIFICATION:GO_CHROMATIN_DISASSEMBLY:GO_PROTEIN_DNA_COMPLEX_DISASSEMBLY:GO_CHROMATIN_REMODELING,HALLMARK_MITOTIC_SPINDLE:HALLMARK_G2M_CHECKPOINT
GSK2798745,Transient receptor potential cation channel subfamily V member 4 antagonist,TRPV4,1,1,3560,3560,NA,71,71,NA,O: 1 U: 0 A: 1,O: 1 U: 0 A: 1,TRPV4,HSF2,Mutation_Gene,NA,TRUE,FALSE,FALSE,Mutation_Gene,,ANTAGONIST,Small molecule,Ion channel,,,CHEMBL3707225,NA:NA:NA:NA:NA,GO_NEURONAL_STEM_CELL_POPULATION_MAINTENANCE:NA:NA:NA:NA,
ELSIGLUTIDE,Glucagon-like peptide 2 receptor agonist,GLP2R,0.8888888888888888,0.7777777777777778,"1017,1341,1602,1785,2826,2967,487,709,791","1017,1341,1602,2826,2967,487,709,791",NA,"27,92,99,173","92,173",NA,O: 8 U: 0 A: 9,O: 2 U: 0 A: 4,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,AGONIST,Protein,Membrane receptor,,,CHEMBL2108318,NA:NA:NA:NA:NA,NA:NA:NA:NA:NA,
TEDUGLUTIDE,Glucagon-like peptide 2 receptor agonist,GLP2R,0.8888888888888888,0.7777777777777778,"1017,1341,1602,1785,2826,2967,487,709,791","1017,1341,1602,2826,2967,487,709,791",NA,"27,92,99,173","92,173",NA,O: 8 U: 0 A: 9,O: 2 U: 0 A: 4,,,Regulon_Gene,NA,TRUE,FALSE,FALSE,Regulon_Gene,,AGONIST,Protein,Membrane receptor,,,CHEMBL2104987,NA:NA:NA:NA:NA,NA:NA:NA:NA:NA,
